MPCI: Strong Uptrend Momentum Against Regulatory Margin PressureMemphis Pharmaceutical & Chemical IndustriesEGX_DLY:MPCImnmabroukw36ix📊 MPCI: Strong Uptrend Momentum Against Regulatory Margin Pressure 📈 🏛️ Fundamentals: 📈 Strengths and Catalysts: State backing via HoldiPharma provides durable order flow in public procurement channels. 🏛️ Strong operational momentum drove TTM EPS growth up +95.1% YoY. 📈 ⚠️ Weaknesses and Risks: High dependence on imported APIs creates foreign exchange friction. ⚠️ Premium valuation metrics at 12.04x P/B leave little buffer for operational misses. 📉 Regulated drug price ceilings limit immediate pass-through of rising cost structures. 🛑 🧾 Shareholders and Free Float: State parent HoldiPharma holds a strategic ~60.0% stake. 🧾 Institutional and corporate investors hold ~16.6%. 💼 Public retail free float stands at ~23.4%. 👥 🕌 Sharia Screen: Sharia status: Non-Compliant due to lack of an official Sharia supervision board and leverage/debt structuring. ⚠️ 📈 The Pulse: Price sits at EGP 418.61 with YTD gains of +185.4% and 1Y gains of +225.1%. 📈 Price remains in a strong primary uptrend wave above key moving averages. 📊 Technical indicators remain positive with liquidity well above average levels. 🟢 Price has not broken any major structural support levels. 🧱 🧱 The Key Structural Boundaries • Support: Hold above the primary green uptrend line. 🟢 • Breakout / Confirmation: Clear break above the red uptrend resistance line. 📈 • Value Entry Zone: Long term accumulation around 345.00. 🎯 • Strategy: Hold existing positions, avoid aggressive new sector entries. 📊 🎯 Verdict: State backing and EPS growth justify trading at a slight premium to peer valuations. 📈 Technical structure remains firmly bullish despite short term sector correction risks. 🟢 Holding current positions stays favored until major trendline boundaries break. 📊 If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑